Eupraxia Pharmaceuticals Inc.

TSX:EPRX.TO

Biotechnology

Healthcare
$8.86 +2.49%

+$0.22 today

Market cap
$595.76M
Beta
1.48
P/E (TTM)
-8.6
EPS (TTM)
-$0.74
52W Low $5.82High $12.86

Volume 0.16M

Average 0.05M

Balance Sheet

Inspect the capital base behind the business.

Assets

$85.99M

FY 2025 · Annual

+146.1% YoY

Liabilities

$5.69M

FY 2025 · Annual

+27.6% YoY

Equity

$80.30M

FY 2025 · Annual

+152.2% YoY

Balance Sheet

Mixed currencies
Metric
FY2021
Dec 2021 · CAD
FY2022
Dec 2022 · CAD
FY2023
Dec 2023 · USD
FY2024
Dec 2024 · USD
FY2025
Dec 2025 · USD
Cash & Equivalents20.89M24.74M19.2M33.1M80.42M
Short-term Investments9.01M0000
Net Receivables337.03K121.51K190.61K228.87K673K
Inventory00000
Other Current Assets151.14K10900(7.02K)
Total Current Assets30.6M25.18M19.8M34.44M84.94M
Property, Plant & Equipment (Net)589.07K695.48K452.97K424.92K985.33K
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets31.37K3.37K6.85K80.76K64.22K
Total Non-current Assets620.44K698.85K459.82K505.68K1.05M
Total Assets31.22M25.88M20.12M34.94M85.99M
Account Payables00000
Short-term Debt74.44K107.53K10.37M71.82K78.31K
Tax Payables0036.16K00
Deferred Revenue003.06K00
Other Current Liabilities1.4M1.55M2.73M(1.5M)1.43M
Total Current Liabilities2.27M4.14M19.23M4.46M5.62M
Long-term Debt9.26M10.3M000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities29.71K0000
Total Non-current Liabilities9.4M10.37M0075.77K
Total Liabilities11.67M14.51M19.23M4.46M5.69M
Common Stock80.71M92.34M69.96M116.36M195.05M
Retained Earnings(74.19M)(97.45M)(79.43M)(131M)(169.27M)
Accumulated OCI00(2.7M)(5.98M)(2.04M)
Other Stockholders Equity00662.23K1.82M0
Minority Interest(833.84K)(1.49M)(1.32M)(1.57M)(1.59M)
Total Equity19.55M11.36M892.33K31.84M80.3M
Total Debt9.49M10.55M10.45M71.86K154.08K
Net Debt(11.4M)(14.19M)(8.83M)(33.03M)(80.26M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$58.5M
Short-term Investments$80.4M
Receivables$663.7K
Other Current$2.6M
Total Current Assets$142.2M
PP&E (Net)$3.2M
Other Non-current$61.8K
Total Non-current Assets$3.2M
Total Assets$145.5M

Analysis

Selected assets total $145.5M for Latest. The largest visible component is Short-term Investments at $80.4M, about 55.3% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

No filings found.

How much cash does EPRX.TO have?

Eupraxia Pharmaceuticals Inc. (EPRX.TO) reported $80.42M in cash and equivalents in fiscal 2025.

How much debt does EPRX.TO carry?

Eupraxia Pharmaceuticals Inc. (EPRX.TO) reported $154,080.00 of total debt, with net debt of -$80.26M.